These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36626226)

  • 1. PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease.
    Chen DP; Aiello CP; McCoy D; Stamey T; Yang J; Hogan SL; Hu Y; Derebail VK; Wu EY; Jennette JC; Falk RJ; Ciavatta DJ
    JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36626226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism.
    Casal Moura M; Deng Z; Brooks SR; Tew W; Fervenza FC; Kallenberg CGM; Langford CA; Merkel PA; Monach PA; Seo P; Spiera RF; St Clair EW; Stone JH; Prunotto M; Grayson PC; Specks U
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36990659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of autoantigen genes in ANCA-associated vasculitis involves alternative transcripts and new protein synthesis.
    McInnis EA; Badhwar AK; Muthigi A; Lardinois OM; Allred SC; Yang J; Free ME; Jennette JC; Preston GA; Falk RJ; Ciavatta DJ
    J Am Soc Nephrol; 2015 Feb; 26(2):390-9. PubMed ID: 25060059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Yang J; Ge H; Poulton CJ; Hogan SL; Hu Y; Jones BE; Henderson CD; McInnis EA; Pendergraft WF; Jennette JC; Falk RJ; Ciavatta DJ
    Clin Epigenetics; 2016; 8():85. PubMed ID: 27752292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation.
    Jones BE; Herrera CA; Agosto-Burgos C; Starmer J; Bass WA; Poulton CJ; Blazek L; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Wu EY; Chen DP; Jennette JC; Free ME; Falk RJ; Ciavatta DJ
    Kidney Int; 2020 Sep; 98(3):744-757. PubMed ID: 32446935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological Interaction of HLA-DPB1 and Proteinase 3 in ANCA Vasculitis is Associated with Clinical Disease Activity.
    Chen DP; McInnis EA; Wu EY; Stember KG; Hogan SL; Hu Y; Henderson CD; Blazek LN; Mallal S; Karosiene E; Peters B; Sidney J; James EA; Kwok WW; Jennette JC; Ciavatta DJ; Falk RJ; Free ME
    J Am Soc Nephrol; 2022 Aug; 33(8):1517-1527. PubMed ID: 35672132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis.
    Jones BE; Yang J; Muthigi A; Hogan SL; Hu Y; Starmer J; Henderson CD; Poulton CJ; Brant EJ; Pendergraft WF; Jennette JC; Falk RJ; Ciavatta DJ
    J Am Soc Nephrol; 2017 Apr; 28(4):1175-1187. PubMed ID: 27821628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis.
    Ciavatta DJ; Yang J; Preston GA; Badhwar AK; Xiao H; Hewins P; Nester CM; Pendergraft WF; Magnuson TR; Jennette JC; Falk RJ
    J Clin Invest; 2010 Sep; 120(9):3209-19. PubMed ID: 20714105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
    Bornstein G; Ben-Zvi I; Furie N; Grossman C
    Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission.
    Ohlsson S; Wieslander J; Segelmark M
    Clin Exp Immunol; 2003 Mar; 131(3):528-35. PubMed ID: 12605707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens.
    Tarzi RM; Liu J; Schneiter S; Hill NR; Page TH; Cook HT; Pusey CD; Woollard KJ
    Clin Exp Immunol; 2015 Jul; 181(1):65-75. PubMed ID: 25766482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Murosaki T; Sato T; Akiyama Y; Nagatani K; Minota S
    Mod Rheumatol; 2017 Jan; 27(1):95-101. PubMed ID: 27320904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective α1-antitrypsin effects in autoimmune vasculitis are compromised by methionine oxidation.
    Ebert M; Jerke U; Eulenberg-Gustavus C; Kling L; Jenne D; Kirchner M; Mertins P; Bieringer M; Elitok S; Eckardt KU; Schreiber A; Salama AD; Kettritz R
    J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36125911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM; Choi SY; Kim SY; Kim J
    Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinction between MPO-ANCA and PR3-ANCA-associated glomerulonephritis in Chinese patients: a retrospective single-center study.
    Hong Y; Shi P; Liu X; Yang L; Li K; Xu F; Liang S; Liu Z; Zhang H; Chen Y; Hu W
    Clin Rheumatol; 2019 Jun; 38(6):1665-1673. PubMed ID: 30737591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab.
    van Dam LS; Dirikgil E; Bredewold EW; Ray A; Bakker JA; van Kooten C; Rabelink TJ; Teng YKO
    Nephrol Dial Transplant; 2021 Jul; 36(8):1408-1417. PubMed ID: 32601673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of different ANCA serotypes on the long-term outcome of ANCA-associated vasculitis patients.
    Qi F; Hao J; Wei W
    Ann Med; 2023; 55(2):2289614. PubMed ID: 38056010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Harper L; Cockwell P; Adu D; Savage CO
    Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population.
    Lundtoft C; Knight A; Meadows JRS; Karlsson Å; Rantapää-Dahlqvist S; Berglin E; Palm Ø; Haukeland H; Gunnarsson I; Bruchfeld A; Segelmark M; Ohlsson S; Mohammad AJ; Eriksson P; Söderkvist P; Ronnblom L; Omdal R; Jonsson R; Lindblad-Toh K; Dahlqvist J
    RMD Open; 2024 Apr; 10(2):. PubMed ID: 38580345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis.
    Holding S; Fisher VJ; Abuzakouk M
    Ann Clin Biochem; 2015 Mar; 52(Pt 2):297-301. PubMed ID: 24723621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.